{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:43:10Z","timestamp":1789670590235,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Fundamental Research Funds for the Central Universities","award":["2042023kf0026"],"award-info":[{"award-number":["2042023kf0026"]}]},{"name":"the Beijing Life Oasis Public Service Center","award":["cphcf-2022-216"],"award-info":[{"award-number":["cphcf-2022-216"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21932-4","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:36:04Z","timestamp":1761831364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ensemble model for neoadjuvant chemotherapy response prediction and treatment sensitivity in TNBC based on DNA replication stress signatures"],"prefix":"10.1038","volume":"15","author":[{"given":"Meishun","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuowan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"21932_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/cncr.35444","volume":"130","author":"MB Nierengarten","year":"2024","unstructured":"Nierengarten, M. B. Global cancer statistics 2022. Cancer 130, 2. https:\/\/doi.org\/10.1002\/cncr.35444 (2024).","journal-title":"Cancer"},{"key":"21932_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752. https:\/\/doi.org\/10.1038\/35021093 (2000).","journal-title":"Nature"},{"key":"21932_CR3","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1002\/cncr.27581","volume":"118","author":"NU Lin","year":"2012","unstructured":"Lin, N. U. et al. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National comprehensive cancer network. Cancer 118, 5463\u20135472. https:\/\/doi.org\/10.1002\/cncr.27581 (2012).","journal-title":"Cancer"},{"key":"21932_CR4","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent, R. et al. Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin. Cancer Res. 13, 4429\u20134434. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-3045 (2007).","journal-title":"Clin. Cancer Res."},{"key":"21932_CR5","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1245\/s10434-021-11223-3","volume":"29","author":"N Tamirisa","year":"2022","unstructured":"Tamirisa, N., Hunt, K. K., Neoadjuvant & Chemotherapy Endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. Ann. Surg. Oncol. 29, 1489\u20131492. https:\/\/doi.org\/10.1245\/s10434-021-11223-3 (2022).","journal-title":"Ann. Surg. Oncol."},{"key":"21932_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar, P. et al. Pathological complete response and long-term clinical benefit in breast cancer: The CTNeoBC pooled analysis. Lancet 384, 164\u2013172. https:\/\/doi.org\/10.1016\/S0140-6736(13)62422-8 (2014).","journal-title":"Lancet"},{"key":"21932_CR7","doi-asserted-by":"publisher","first-page":"e071674","DOI":"10.1136\/bmj-2022-071674","volume":"381","author":"RA Leon-Ferre","year":"2023","unstructured":"Leon-Ferre, R. A. & Goetz, M. P. Advances in systemic therapies for triple negative breast cancer. BMJ 381, e071674. https:\/\/doi.org\/10.1136\/bmj-2022-071674 (2023).","journal-title":"BMJ"},{"key":"21932_CR8","doi-asserted-by":"publisher","unstructured":"Garufi, G. et al. Updated neoadjuvant treatment landscape for early triple negative breast cancer: Immunotherapy, potential predictive Biomarkers, and novel agents. Cancers (Basel). 14. https:\/\/doi.org\/10.3390\/cancers14174064 (2022).","DOI":"10.3390\/cancers14174064"},{"key":"21932_CR9","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/jcp.26103","volume":"233","author":"T Gamucci","year":"2018","unstructured":"Gamucci, T. et al. Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting. J. Cell. Physiol. 233, 2313\u20132323. https:\/\/doi.org\/10.1002\/jcp.26103 (2018).","journal-title":"J. Cell. Physiol."},{"key":"21932_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-012414-040424","volume":"10","author":"M Macheret","year":"2015","unstructured":"Macheret, M. & Halazonetis, T. D. DNA replication stress as a hallmark of cancer. Annu. Rev. Pathol. 10, 425\u2013448. https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040424 (2015).","journal-title":"Annu. Rev. Pathol."},{"key":"21932_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2897","volume":"16","author":"MK Zeman","year":"2014","unstructured":"Zeman, M. K. & Cimprich, K. A. Causes and consequences of replication stress. Nat. Cell. Biol. 16, 2\u20139. https:\/\/doi.org\/10.1038\/ncb2897 (2014).","journal-title":"Nat. Cell. Biol."},{"key":"21932_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41568-022-00518-6","volume":"23","author":"E Cybulla","year":"2023","unstructured":"Cybulla, E. & Vindigni, A. Leveraging the replication stress response to optimize cancer therapy. Nat. Rev. Cancer. 23, 6\u201324. https:\/\/doi.org\/10.1038\/s41568-022-00518-6 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"21932_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","volume":"22","author":"A da Costa","year":"2023","unstructured":"da Costa, A., Chowdhury, D., Shapiro, G. I., D\u2019Andrea, A. D. & Konstantinopoulos, P. A. Targeting replication stress in cancer therapy. Nat. Rev. Drug Discov. 22, 38\u201358. https:\/\/doi.org\/10.1038\/s41573-022-00558-5 (2023).","journal-title":"Nat. Rev. Drug Discov"},{"key":"21932_CR14","doi-asserted-by":"publisher","unstructured":"Makhale, A., Nanayakkara, D., Raninga, P., Khanna, K. K. & Kalimutho, M. CX-5461 enhances the efficacy of APR-246 via induction of DNA damage and replication stress in Triple-Negative breast cancer. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22115782 (2021).","DOI":"10.3390\/ijms22115782"},{"key":"21932_CR15","doi-asserted-by":"publisher","unstructured":"Jegadesan, N. K. & Branzei, D. DDX11 loss causes replication stress and pharmacologically exploitable DNA repair defects. Proc. Natl. Acad. Sci. U. S. A. 118 https:\/\/doi.org\/10.1073\/pnas.2024258118 (2021).","DOI":"10.1073\/pnas.2024258118"},{"key":"21932_CR16","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1001\/jama.2011.593","volume":"305","author":"C Hatzis","year":"2011","unstructured":"Hatzis, C. et al. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305, 1873\u20131881. https:\/\/doi.org\/10.1001\/jama.2011.593 (2011).","journal-title":"JAMA"},{"key":"21932_CR17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.1665","volume":"28","author":"L Shi","year":"2010","unstructured":"Shi, L. et al. The microarray quality control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat. Biotechnol. 28, 827\u2013838. https:\/\/doi.org\/10.1038\/nbt.1665 (2010).","journal-title":"Nat. Biotechnol."},{"key":"21932_CR18","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.1158\/1078-0432.CCR-10-1265","volume":"16","author":"A Tabchy","year":"2010","unstructured":"Tabchy, A. et al. Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer. Clin. Cancer Res. 16, 5351\u20135361. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1265 (2010).","journal-title":"Clin. Cancer Res."},{"key":"21932_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy\u2013analysis of affymetrix genechip data at the probe level. Bioinformatics 20, 307\u2013315. https:\/\/doi.org\/10.1093\/bioinformatics\/btg405 (2004).","journal-title":"Bioinformatics"},{"key":"21932_CR20","doi-asserted-by":"publisher","unstructured":"Dreyer, S. B. et al. Targeting DNA damage response and replication stress in pancreatic cancer. Gastroenterology 160, 362\u2013377 (2021). https:\/\/doi.org\/10.1053\/j.gastro.2020.09.043","DOI":"10.1053\/j.gastro.2020.09.043"},{"key":"21932_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12967-023-03872-7","volume":"21","author":"RH Huang","year":"2023","unstructured":"Huang, R. H. et al. A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer. J. Transl. Med. 21, 20. https:\/\/doi.org\/10.1186\/s12967-023-03872-7 (2023).","journal-title":"J. Transl Med."},{"key":"21932_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i11","volume":"36","author":"MB Kursa","year":"2010","unstructured":"Kursa, M. B. & Rudnicki, W. R. Feature selection with the Boruta package. J. Stat. Softw. 36, 1\u201313. https:\/\/doi.org\/10.18637\/jss.v036.i11 (2010).","journal-title":"J. Stat. Softw."},{"key":"21932_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn, M. Building predictive models in R using the caret package. J. Stat. Softw. 28, 1\u201326. https:\/\/doi.org\/10.18637\/jss.v028.i05 (2008).","journal-title":"J. Stat. Softw."},{"key":"21932_CR24","unstructured":"Ripley, B. D. Pattern Recognition and Neural Networks (Cambridge University Press, 2007)."},{"key":"21932_CR25","doi-asserted-by":"publisher","unstructured":"Wright, M. N. & Ziegler, A. Ranger: A fast implementation of random forests for high dimensional data in C\u2009+\u2009+\u2009and R. J. Stat. Softw. 77 https:\/\/doi.org\/10.18637\/jss.v077.i01 (2017).","DOI":"10.18637\/jss.v077.i01"},{"key":"21932_CR26","unstructured":"Chen, T. & Guestrin, C. In Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining. 785\u2013794."},{"key":"21932_CR27","unstructured":"Rish, I. In IJCAI 2001 workshop on empirical methods in artificial intelligence. 41\u201346."},{"issue":"5","key":"21932_CR28","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1214\/aos\/1013203451","volume":"29","author":"JH Friedman","year":"2001","unstructured":"Friedman, J. H. Greedy function approximation: A gradient boosting machine. Annals Stat. 29 (5), 1189\u20131232 (2001).","journal-title":"Annals Stat."},{"key":"21932_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/bf00994018","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes, C., Vapnik, V., Support-vector & networks. Mach. Learn. 20, 273\u2013297. https:\/\/doi.org\/10.1007\/bf00994018 (1995).","journal-title":"Mach. Learn."},{"key":"21932_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2307\/2344614","volume":"135","author":"JA Nelder","year":"1972","unstructured":"Nelder, J. A. & Wedderburn, R. W. Generalized linear models. J. R. Stat. Soc. Ser. A-Gen. 135, 370\u2013. https:\/\/doi.org\/10.2307\/2344614 (1972).","journal-title":"J. Royal Stat. Soc. Ser. a-General"},{"key":"21932_CR31","doi-asserted-by":"publisher","unstructured":"Oshi, M. et al. A novel Three-Gene score as a predictive biomarker for pathologically complete response after neoadjuvant chemotherapy in Triple-Negative breast cancer. Cancers (Basel). 13. https:\/\/doi.org\/10.3390\/cancers13102401 (2021).","DOI":"10.3390\/cancers13102401"},{"key":"21932_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10549-021-06442-x","volume":"191","author":"K Zuo","year":"2022","unstructured":"Zuo, K. et al. qRT-PCR-based DNA homologous recombination-associated 4-gene score predicts pathologic complete response to platinum-based neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res. Treat. 191, 335\u2013344. https:\/\/doi.org\/10.1007\/s10549-021-06442-x (2022).","journal-title":"Breast Cancer Res. Treat."},{"key":"21932_CR33","doi-asserted-by":"publisher","first-page":"936","DOI":"10.7150\/jca.52439","volume":"12","author":"Y Han","year":"2021","unstructured":"Han, Y., Wang, J. & Xu, B. Novel biomarkers and prediction model for the pathological complete response to neoadjuvant treatment of triple-negative breast cancer. J. Cancer. 12, 936\u2013945. https:\/\/doi.org\/10.7150\/jca.52439 (2021).","journal-title":"J. Cancer"},{"key":"21932_CR34","doi-asserted-by":"publisher","first-page":"14863","DOI":"10.1038\/s41598-019-51335-1","volume":"9","author":"MV Fournier","year":"2019","unstructured":"Fournier, M. V. et al. A predictor of pathological complete response to neoadjuvant chemotherapy stratifies triple negative breast cancer patients with high risk of recurrence. Sci. Rep. 9, 14863. https:\/\/doi.org\/10.1038\/s41598-019-51335-1 (2019).","journal-title":"Sci. Rep."},{"key":"21932_CR35","doi-asserted-by":"publisher","unstructured":"Park, S. & Yi, G. Development of gene Expression-Based random forest model for predicting neoadjuvant chemotherapy response in Triple-Negative breast cancer. Cancers (Basel). 14. https:\/\/doi.org\/10.3390\/cancers14040881 (2022).","DOI":"10.3390\/cancers14040881"},{"key":"21932_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25\u201329. https:\/\/doi.org\/10.1038\/75556 (2000).","journal-title":"Nat. Genet."},{"key":"21932_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. K. E. G. G. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"21932_CR38","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"21932_CR39","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. (Camb). 2, 100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141 (2021).","journal-title":"Innov. (Camb)"},{"key":"21932_CR40","doi-asserted-by":"publisher","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 14 https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","DOI":"10.1186\/1471-2105-14-7"},{"key":"21932_CR41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: Digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220. https:\/\/doi.org\/10.1186\/s13059-017-1349-1 (2017).","journal-title":"Genome Biol."},{"key":"21932_CR42","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li, T. et al. A web server for comprehensive analysis of Tumor-Infiltrating immune cells. Cancer Res. 77, e108\u2013e110. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307 (2017).","journal-title":"Cancer Res."},{"key":"21932_CR43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/bs.mie.2019.05.056","volume":"636","author":"C Plattner","year":"2020","unstructured":"Plattner, C., Finotello, F. & Rieder, D. Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quantiseq. Methods Enzymol. 636, 261\u2013285. https:\/\/doi.org\/10.1016\/bs.mie.2019.05.056 (2020).","journal-title":"Methods Enzymol."},{"key":"21932_CR44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218. https:\/\/doi.org\/10.1186\/s13059-016-1070-5 (2016).","journal-title":"Genome Biol."},{"key":"21932_CR45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-1-0716-0327-7_17","volume":"2120","author":"J Racle","year":"2020","unstructured":"Racle, J. & Gfeller, D. E. P. I. C. A tool to estimate the proportions of different cell types from bulk gene expression data. Methods Mol. Biol. (Clifton N. J.). 2120, 233\u2013248. https:\/\/doi.org\/10.1007\/978-1-0716-0327-7_17 (2020).","journal-title":"Methods Mol. Biology (Clifton N J)"},{"key":"21932_CR46","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782. https:\/\/doi.org\/10.1038\/s41587-019-0114-2 (2019).","journal-title":"Nat. Biotechnol."},{"key":"21932_CR47","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612. https:\/\/doi.org\/10.1038\/ncomms3612 (2013).","journal-title":"Nat. Commun."},{"key":"21932_CR48","doi-asserted-by":"publisher","unstructured":"Maeser, D., Gruener, R. F. & Huang, R. S. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief. Bioinform. 22 https:\/\/doi.org\/10.1093\/bib\/bbab260 (2021).","DOI":"10.1093\/bib\/bbab260"},{"key":"21932_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1467-985X.2010.00676_9.x","volume":"174","author":"C Ginestet","year":"2011","unstructured":"Ginestet, C. ggplot2: elegant graphics for data analysis. J. R Stat. Soc. Ser. A-Stat. Soc. 174, 245\u2013245. https:\/\/doi.org\/10.1111\/j.1467-985X.2010.00676_9.x (2011).","journal-title":"J. R Stat. Soc. Ser. A-Stat Soc."},{"key":"21932_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41598-020-80081-y","volume":"11","author":"K Anand","year":"2021","unstructured":"Anand, K. et al. Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy. Sci. Rep. 11, 82. https:\/\/doi.org\/10.1038\/s41598-020-80081-y (2021).","journal-title":"Sci. Rep."},{"key":"21932_CR51","doi-asserted-by":"publisher","unstructured":"Tang, X. et al. Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors. Breast Cancer Res. 25 https:\/\/doi.org\/10.1186\/s13058-023-01656-x (2023).","DOI":"10.1186\/s13058-023-01656-x"},{"key":"21932_CR52","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","volume":"82","author":"S Saxena","year":"2022","unstructured":"Saxena, S. & Zou, L. Hallmarks of DNA replication stress. Mol. Cell. 82, 2298\u20132314. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.004 (2022).","journal-title":"Mol. Cell."},{"key":"21932_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pharmthera.2019.05.009","volume":"11","author":"J Murai","year":"2019","unstructured":"Murai, J., Thomas, A., Miettinen, M., Pommier, Y. & Schlafen SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies. Pharmacol. Ther. 201. 11, 94\u2013102. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.05.009 (2019).","journal-title":"Pharmacol. Ther. 201"},{"key":"21932_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener, J. G., Kandathil, S. M., Moffat, L. & Jones, D. T. A guide to machine learning for biologists. Nat. Rev. Mol. Cell. Biol. 23, 40\u201355. https:\/\/doi.org\/10.1038\/s41580-021-00407-0 (2022).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"21932_CR55","doi-asserted-by":"publisher","unstructured":"Xiong, Y., Ye, M. & Wu, C. Cancer classification with a Cost-Sensitive Naive Bayes stacking ensemble. Comput. Math. Methods Med. 2021 (5556992). https:\/\/doi.org\/10.1155\/2021\/5556992 (2021).","DOI":"10.1155\/2021\/5556992"},{"key":"21932_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s0893-6080(05)80023-1","volume":"5","author":"DH Wolpert","year":"1992","unstructured":"Wolpert, D. H. Stacked generalization. Neural Netw. 5, 241\u2013259. https:\/\/doi.org\/10.1016\/s0893-6080(05)80023-1 (1992).","journal-title":"Neural Netw."},{"key":"21932_CR57","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00259-022-06038-7","volume":"50","author":"Y Onozato","year":"2023","unstructured":"Onozato, Y. et al. Predicting pathological highly invasive lung cancer from preoperative [(18)F]FDG PET\/CT with multiple machine learning models. Eur. J. Nucl. Med. Mol. Imaging. 50, 715\u2013726. https:\/\/doi.org\/10.1007\/s00259-022-06038-7 (2023).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"21932_CR58","doi-asserted-by":"publisher","unstructured":"Mahajan, P., Uddin, S., Hajati, F. & Moni, M. A. Ensemble learning for disease prediction: A review. Healthc. (Basel). 11 https:\/\/doi.org\/10.3390\/healthcare11121808 (2023).","DOI":"10.3390\/healthcare11121808"},{"key":"21932_CR59","doi-asserted-by":"publisher","first-page":"104683","DOI":"10.1016\/j.phrs.2020.104683","volume":"153","author":"KGK Deepak","year":"2020","unstructured":"Deepak, K. G. K. et al. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol. Res. 153, 104683. https:\/\/doi.org\/10.1016\/j.phrs.2020.104683 (2020).","journal-title":"Pharmacol. Res."},{"key":"21932_CR60","doi-asserted-by":"publisher","first-page":"115425","DOI":"10.1016\/j.biopha.2023.115425","volume":"166","author":"Z Zhao","year":"2023","unstructured":"Zhao, Z., Li, T., Sun, L., Yuan, Y. & Zhu, Y. Potential mechanisms of cancer-associated fibroblasts in therapeutic resistance. Biomed. Pharmacother. 166, 115425. https:\/\/doi.org\/10.1016\/j.biopha.2023.115425 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"21932_CR61","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao, X. et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: New findings and future perspectives. Mol. Cancer. 20, 131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1 (2021).","journal-title":"Mol. Cancer"},{"key":"21932_CR62","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.7150\/thno.68972","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. FGFR Blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts. Theranostics 12, 4564\u20134580. https:\/\/doi.org\/10.7150\/thno.68972 (2022).","journal-title":"Theranostics"},{"key":"21932_CR63","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.2147\/IJN.S418100","volume":"18","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Co-Delivery nanomicelles for potentiating TNBC immunotherapy by synergetically reshaping CAFs-Mediated tumor stroma and reprogramming immunosuppressive microenvironment. Int. J. Nanomed. 18, 4329\u20134346. https:\/\/doi.org\/10.2147\/IJN.S418100 (2023).","journal-title":"Int. J. Nanomed."},{"key":"21932_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2023.01.001","volume":"184","author":"PA Fasching","year":"2023","unstructured":"Fasching, P. A. et al. Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer\u2014A single-arm phase II trial (NeoImmunoboost, AGO-B-041). Eur. J. Cancer. 184, 1\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2023.01.001 (2023).","journal-title":"Eur. J. Cancer"},{"key":"21932_CR65","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41523-022-00500-3","volume":"8","author":"FO Ademuyiwa","year":"2022","unstructured":"Ademuyiwa, F. O. et al. A randomized phase 2 study of neoadjuvant carboplatin and Paclitaxel with or without Atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ Breast Cancer. 8, 134. https:\/\/doi.org\/10.1038\/s41523-022-00500-3 (2022).","journal-title":"NPJ Breast Cancer"},{"key":"21932_CR66","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","volume":"36","author":"MC Mendoza","year":"2011","unstructured":"Mendoza, M. C., Er, E. E. & Blenis, J. The Ras-ERK and PI3K-mTOR pathways: Cross-talk and compensation. Trends Biochem. Sci. 36, 320\u2013328. https:\/\/doi.org\/10.1016\/j.tibs.2011.03.006 (2011).","journal-title":"Trends Biochem. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21932-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21932-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21932-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:36:05Z","timestamp":1761831365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21932-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21932"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21932-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38079"}}